ABCL
ABCL
NASDAQ · Life Sciences Tools & Services

Abcellera Biologics Inc

$3.52
+0.21 (+6.34%)
As of Mar 25, 2:11 PM ET ·
Day Range $3.37 — $3.53
52W Range $1.89 — $6.52
Open$3.40
Previous Close$3.31
Day High$3.53
Day Low$3.37
52W High$6.52
52W Low$1.89
Volume
Avg Volume2.55M
Market Cap1.07B
P/E Ratio
EPS$-0.49
SectorLife Sciences Tools & Services

Analyst Ratings

Strong Buy
14 analysts
12 Buy 2 Hold 0 Sell
Price Target +1,173.0% upside
Current
$3.52
Target
$44.81
$32.90 $44.81 avg $56.58

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 75.60M 140.81M 396.65M
Net Income -147,356,942 -247,012,940 43.78M
Profit Margin -194.9% -185.1% 11.0%
EBITDA -185,924,661 -328,978,260 99.33M
Free Cash Flow 67.30M
Rev Growth -46.3% -46.3% +18.5%
Debt/Equity 0.27

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $490.77 +0.10% 26.1 175.01B
DHR Danaher Corp $187.15 -1.55% 37.1 133.90B
A Agilent Technologies Inc $112.98 -1.07% 24.4 31.51B
IQV Iqvia Holdings Inc $165.64 -0.27% 20.8 28.25B
MTD Mettler-Toledo International $1,265.75 +0.10% 29.5 25.63B
WAT Waters Corp $302.32 +0.13% 28.1 18.02B

ABCL News

No news for ABCL yet

Quick Stats

Market Cap1.07B
P/E Ratio
EPS$-0.49
Volume
SectorLife Sciences Tools & Services